Literature DB >> 11583154

High-resolution solution structure of human intestinal trefoil factor and functional insights from detailed structural comparisons with the other members of the trefoil family of mammalian cell motility factors.

X Lemercinier1, F W Muskett, B Cheeseman, P B McIntosh, L Thim, M D Carr.   

Abstract

The secreted proteins intestinal trefoil factor (ITF, 59 residues), pS2 (60 residues), and spasmolytic polypeptide (SP, 106 residues) form a small family of trefoil domain-containing mammalian cell motility factors, which are essential for the maintenance of all mucous-coated epithelial surfaces. We have used 1H NMR spectroscopy to determine the high-resolution structure of human ITF, which has allowed detailed structural comparisons with the other trefoil cell motility factors. The conformation of residues 10-53 of hITF is determined to high precision, but the structure of the N- and C-terrminal residues is poorly defined by the NMR data, which is probably indicative of significant mobility. The core of the trefoil domain in hITF consists of a two-stranded antiparallel beta-sheet (Cys 36 to Asp 39 and Trp 47 to Lys 50), which is capped by an irregular loop and forms a central hairpin (loop 3). The beta-sheet is preceded by a short alpha-helix (Lys 29 to Arg 34), with the majority of the remainder of the domain contained in two loops formed from His 25 to Pro 28 (loop 2) and Ala 12 to Arg 18 (loop 1), which lie on either side of the central hairpin. The region formed by the surface of loop 2, the cleft between loop 2 and loop 3, and the adjacent face of loop 3 has previously been proposed to form the functional site of trefoil domains. Detailed comparisons of the backbone conformations and surface features of the family of trefoil cell motility factors (porcine SP, pS2, and hITF) have identified significant structural and electrostatic differences in the loop 2/loop 3 regions, which suggest that each trefoil protein has a specific target or group of target molecules.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583154     DOI: 10.1021/bi010184+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

2.  Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.

Authors:  Julie M Kneller; Thomas Ehlen; Jasenka P Matisic; Dianne Miller; Dirk Van Niekerk; Wan L Lam; Marco Marra; Rebecca Richards-Kortum; Michelle Follen; Calum Macaulay; Steven J M Jones
Journal:  Biomark Insights       Date:  2007-12-11

3.  Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6.

Authors:  Philip S Renshaw; Kirsty L Lightbody; Vaclav Veverka; Fred W Muskett; Geoff Kelly; Thomas A Frenkiel; Stephen V Gordon; R Glyn Hewinson; Bernard Burke; Jim Norman; Richard A Williamson; Mark D Carr
Journal:  EMBO J       Date:  2005-06-23       Impact factor: 11.598

4.  Evolution of trefoil factor(s): genetic and spatio-temporal expression of trefoil factor 2 in the chicken (Gallus gallus domesticus).

Authors:  Zhengyu Jiang; Amy C Lossie; Todd J Applegate
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

5.  Chemical Synthesis of TFF3 Reveals Novel Mechanistic Insights and a Gut-Stable Metabolite.

Authors:  Nayara Braga Emidio; Rajeshwari Meli; Hue N T Tran; Hayeon Baik; Séverine Morisset-Lopez; Alysha G Elliott; Mark A T Blaskovich; Sabrina Spiller; Annette G Beck-Sickinger; Christina I Schroeder; Markus Muttenthaler
Journal:  J Med Chem       Date:  2021-06-18       Impact factor: 7.446

6.  The trefoil factor interacting protein TFIZ1 binds the trefoil protein TFF1 preferentially in normal gastric mucosal cells but the co-expression of these proteins is deregulated in gastric cancer.

Authors:  Felicity E B May; S Michael Griffin; Bruce R Westley
Journal:  Int J Biochem Cell Biol       Date:  2008-08-03       Impact factor: 5.085

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.